Invention Grant
- Patent Title: Hepatitis C virus inhibitors
-
Application No.: US14807084Application Date: 2015-07-23
-
Publication No.: US09776981B2Publication Date: 2017-10-03
- Inventor: Rico Lavoie , John A. Bender , Zhong Yang , Makonen Belema , Omar D. Lopez , Qi Chen , Gan Wang , Piyasena Hewawasam
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Pamela A. Mingo
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D309/06 ; C07D401/14 ; C07D403/14 ; C07D471/04 ; A61K31/4178 ; A61K31/4184 ; A61K31/437 ; A61K31/4375 ; A61K31/4545 ; A61K31/4709 ; A61K31/498 ; A61K31/4985 ; A61K31/5377 ; A61K45/06 ; C07D403/10 ; C07D405/14 ; C07D413/14
Abstract:
The present disclosure relates to compounds, compositions and methods for the treatment of Hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
Public/Granted literature
- US20150322048A1 Hepatitis C Virus Inhibitors Public/Granted day:2015-11-12
Information query
